Private Label: o potencial impacto no mercado de medicamentos no Brasil
The objective of this article is to discuss how the release of private labels would change the dynamics of the industry with the eventual concentration of the retailer’s power in the medicines market. To this end, important theoretical aspects will be raised, based, for example, on Michael Porter’s theory (Five Competitive Forces and Value Chain). As a
Ronaldo Raemy Rangel +2 more
openaire +2 more sources
[Disease, social, and economic burden of smoking in Brazil and the impact of tax increases on the economy and on the reduction of morbidity and mortality]. [PDF]
Pinto M +13 more
europepmc +1 more source
[Technological and market analysis of the hemodialysis membranes segment in Brazil based on federal public procurement data]. [PDF]
Barcelos GFJ +3 more
europepmc +1 more source
[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]
Marín GH +7 more
europepmc +1 more source
Prices paid for primary health care medicines by Brazilian municipalities. [PDF]
Silva WROD +5 more
europepmc +1 more source
Prevalence and factors associated with self-medication among schoolchildren in the Metropolitan Region of Vitória, Brazil. [PDF]
Mairink KR +6 more
europepmc +1 more source
Direct cost of ultrasound-guided outpatient medical procedures for patients with pain. [PDF]
Paim OP, Rached RDVA, Lima AFC.
europepmc +1 more source
[The survival of Antiquity on the covers and int he drug ads of Eu Sei Tudo magazine, 1917-1958]. [PDF]
Maia ACN, Liborio DS.
europepmc +1 more source
[Extension of the term of validity of pharmaceutical patents by lawsuits: effects on centralized procurement and the private market]. [PDF]
Paranhos J +4 more
europepmc +1 more source
Consumption of drugs for Alzheimer's disease on the Brazilian private market. [PDF]
Freitas EL +4 more
europepmc +1 more source

